NovaBay Pharmaceuticals, Inc. Additional Paid In Capital

Additional Paid In Capital of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Additional Paid In Capital growth rates and interactive chart.


Highlights and Quick Summary

  • Additional Paid In Capital for the quarter ending September 30, 2022 was $163 Million (a 2.34% increase compared to previous quarter)
  • Year-over-year quarterly Additional Paid In Capital increased by 7.69%
  • Annual Additional Paid In Capital for 2021 was $151 Million (a 1.98% increase from previous year)
  • Annual Additional Paid In Capital for 2020 was $148 Million (a 17.69% increase from previous year)
  • Annual Additional Paid In Capital for 2019 was $126 Million (a 4.97% increase from previous year)
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Additional Paid In Capital of NovaBay Pharmaceuticals, Inc.

Most recent Additional Paid In Capitalof NBY including historical data for past 10 years.

Interactive Chart of Additional Paid In Capital of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Additional Paid In Capital for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $162.51 $158.79 $158.62
2021 $150.9 $150.64 $150.2 $148.15 $150.9
2020 $147.96 $147.77 $131.73 $125.98 $147.96
2019 $125.72 $125.01 $123.52 $120.48 $125.72
2018 $119.76 $119.6 $119.43 $119.29 $119.76
2017 $113.51 $113.55 $112.48 $111.89 $113.51
2016 $110.62 $108.59 $95.73 $88.25 $110.62
2015 $85.39 $85.8 $85.24 $77.73 $85.39
2014 $73.37 $72.27 $71.59 $71.26 $73.37
2013 $64.44 $57.26 $55.22 $54.3 $64.44
2012 $54.0 $45.14 $43.43 $42.94 $54.0
2011 $42.39 $42.39

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology